Allelic frequencies of HPA-1 to 5 human platelet antigens in patients infected with hepatitis C virus

Journal of Medical Virology

Volumn 81, Issue 4, 2009, Pages 757-759

  Verdichio Moraes, Camila Fernanda ^a   Toralles Pereira, Cecília ^a   Grotto, Rejane Maria Tommasini ^a   Silva, Giovanni Faria ^a   De Pardini, Maria Inês Moura Campos ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Allelic frequencies; Hepatitis c virus; Human platelet antigens; Platelets

Indexed keywords

HUMAN PLATELET ANTIGEN 1; HUMAN PLATELET ANTIGEN 2; HUMAN PLATELET ANTIGEN 3; HUMAN PLATELET ANTIGEN 4; HUMAN PLATELET ANTIGEN 5; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG; 5B ALLOANTIGEN, HUMAN;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; GENE FREQUENCY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ALLELE; BLOOD; BLOOD DONOR; GENETICS; IMMUNOLOGY; THROMBOCYTE; VIROLOGY;

HEPATITIS C VIRUS;

ALLELES; ANTIGENS, HUMAN PLATELET; BLOOD DONORS; BLOOD PLATELETS; GENE FREQUENCY; HEPACIVIRUS; HEPATITIS C; HUMANS;

EID: 62849128646     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21411     Document Type: Article

References (28)

1. Almarri A, El-Dwick N, Al-Kabi S, Sleem K, Rashed A, Ritter MA, Batchelor JR. 1998. Interferon alpha therapy in HCV hepatitis: HLA phenotype and cirrhosis are independent predictors of clinical outcome. Hum Immunol 59:239-242.
2. Asti M, Martinetti M, Zavaglia C, Cuccia MC, Gusberti L, Tinelli C, Cividini A, Bruno S, Salvaneschi L, Ideo G, Mondelli MU, Silini EM. 1999. Human leukocyte antigen class II and III alleles and severity of hepatitis C virus related chronic liver disease. Hepatology 29: 1272-1279.
3. Ayala F, Corral J, González-Conejero R, Sanchez I, Moraleda JM, Vicente V. 2003. Genetic polymorphisms of platelet adhesive molecules: Association with breast cancer risk and clinical presentation. Breast Cancer Res Treat 80:145-154.
4. Barth H, Schäfer C, Adah MI, Zhang F, Linhard RJ, Toyoda H, Kinoshita-Toyoda A, Toida T, Van Kuppevelt TH, Depla E, Von Weizsacker F, Blum HE, Baumert TF. 2003. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparin sulfate. J Biol Chem 278:41003-41012.
5. Bussel J, Kaplan C. 1998. The fetal and neonatal consequences of maternal alloimmune thrombocytopenia (Review). Baillieres Clin Haematol 11:3911 -3918.
6. Cavanagh G, Dunn AN, Chapman CE, Metcalfe P. 1997. HPA genotyping by PCR sequence-specific priming (PCR-SSP): A streamlined method for rapid routine investigations. Transfus Med 7:41-45.
7. Clemetson KJ. 2003. Platelet receptors and their role in diseases. Clin Chem Lab Med 41:253-260.
8. García-Malo MD, Corral J, González M, Solano C, González-Conejero R, Caballero MD, Pérez R, Moraleda JM, Vicente V. 2004. Human platelet antigen systems in allogeneic peripheral blood progenitor cell transplantation: Effect of human platelet antigen mismatch on platelet engraftment and graft- versus -host disease. Transfusion 44:771-776.
9. Goutagny N, Fatmi A, De Ledinghen V, Penin F, Couzigou P, Ichauspe G. 2003. Evidence of viral replication in circulating dendritic cells during hepatitis C virus infection. J Infect Dis 187:1951 -1958.
10. Hamaia S, Li C, Allain JP. 2001. The dynamics of hepatitis C virus binding to platelets and 2 mononuclear cell lines. Blood 98:2293-2300.
11. Hüe S, Cacoub P, Renou C, Halfon P, Thibault V, Charlotte F, Picon M, Rifflet H, Piette JC, Pol S, Caillat-Zucman S. 2002. Human leukocyte antigen class II alleles may contribute to the severity of hepatitis C virus related liver disease. J Infect Dis 186:106-109.
12. Iniesta JA, González-Conejero R, Piqueras C, Vicente V, Corral J. 2004. Platelet GP IIIa polymorphism HPA-1 (P1A) protects against subarachnoid hemorrhage. Stroke 35:2282-2286.
13. Jurado A, Cárdaba B, Jara P, Cuadrado P, Hierro L, de AndrésB, Del Pozo V, Cortegano MI, Gallardo S, Camarena C, Bárcena R, Castaner JL, Alvarez R, Lahoz C, Palomino P. 1997. Autoimmune hepatitis type 2 and hepatitis C virus infection: Study of HLA antigens. J Hepatol 26:983-991.
14. Kalb R, Santoso S, Unkelbach K, Kiefel V, Mueller-Eckhardt C. 1994. Localization of the Br polymorphism on a 144bp exon of the GPIa gene and its application for platelet DNA typing. Thromb Haemost 71:651-654.
15. Klüter H, Fehlau K, Panzer S, Kirchner H, Bein G. 1996. Rapid typing for human platelet antigen systems-1, -2, -3 and -5 by PCR amplification with sequence-specific primers. Vox Sang 71:121-125.
16. Kunicki TJ, Newman PJ. 1992. The molecular immunology of platelet proteins. Blood 80:1386-1404.
17. Lauer GM, Walker BD. 2001. Hepatitis C virus infection. N Engl J Med 345:41-52.
18. Metcalfe P. 2004. Platelet antigens and antibody detection. Vox Sang 87:S82-S86.
19. Metcalfe P, Watkins NA, Ouwehand WH, Kaplan C, Newman P, Kekomaki R, De Haas M, Aster R, Shibata Y, Smith J, Kiefel V, Santoso S. 2003. Nomenclature of human platelet antigens. Vox Sang 85:240-245.
20. Minton EJ, Smillie D, Neal KR, Irving WL, Underwood JC, James V. 1998. Association between MHC Class II alleles and clearance of circulating hepatitis C virus. J Infect Dis 178:39-44.
21. Muller HM, Pfaff E, Goeser T, Kallinwski B, Solbach C, Thielman L. 1995. Peripheral blood leukocytes serve as a possible extra hepatic site for hepatitis C virus replication. J Gen Virol 74:669.
22. Muller-Eckhardt C, Kiefel V, Santoso S. 1990. Review and update of platelet alloantigen systems. Transfus Med 4:98.
23. Pavio N, Lai MMC. 2003. The hepatitis C virus persistence: How to evade the immune system? J Biosci 28:287-304.
24. Pugliese A, Gennero L, Cutufia M, Enrietto M, Morra E, Pescarmona P, Ponzetto A. 2004. HCV infective virions can be carried by human platelets. Cell Biochem Funct 22:353-358.
25. Reiner AP, Kumar PN, Schwartz SM, Longstreth WT Jr, Pearce RM, Rosendaal FR, Psaty BM, Siscovick DS. 2000. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women. Stroke 31:1628-1633.
26. A1/A2 polymorphism ofplatelet glycoprotein IIIa and risks of myocardial infarction, stroke and venous thrombosis. Lancet 349:385-388.
27. Rosenberg N, Zivelin A, Chetrit A, Dardik R, Kornbrot N, Freimark D, Inbal A. 2002. Effects of platelet membrane glycoprotein polymorphisms on the risk of myocardial infarction in young males. IMAJ 4:411-414.
28. Thursz M, Yallop R, Goldin R, Trepo C, Thomas HC. 1999. Influence of MHC class II genotype on outcome of infection with hepatitis C virus. Lancet 354:2119-2124.